Anti-Cofilin (phospho S3) 抗体
Anti-Cofilin (phospho S3) antibody
- Lab Essentials
- 詳細を見る
4
(9 Reviews)
|
(82 Publications)
Rabbit Polyclonal Cofilin-1 phospho S3 antibody. Suitable for ICC/IF, Flow Cyt, WB and reacts with Human, African green monkey, Mouse, Dog, Rat samples. Cited in 82 publications.
別名を表示する
CFL, CFL1, Cofilin-1, 18 kDa phosphoprotein, p18
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cofilin (phospho S3) antibody (AB12866)
ICC/IF image of ab12866 stained MCF7 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab12866, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-Cofilin (phospho S3) antibody (AB12866)
Flow Cytometry analysis of U-87 MG cells labeling Cofilin (phospho S3) with ab12866. Cells were fixed with 70% ethanol for 10 minutes, permeabilized with 0.25% Triton™ X-100 for 20 minutes, and blocked with 5% BSA for 30 minutes at room temperature. Cells were labeled with Anti-Cofilin (phospho S3) antibody (ab12866, red) or with rabbit isotype control (pink) at 3-5 ug/million cells in 2.5% BSA. After incubation at room temperature for 2 hours, the cells were labeled with Alexa Fluor® 488 Goat Anti-Rabbit Secondary Antibody at a dilution of 1/400 for 30 minutes at room temperature. The representative 10,000 cells were acquired and analyzed for each sample. The purple histogram represents unstained control cells and the green histogram represents no-primary-antibody control.
- ICC/IF
AbReview31575****
Immunocytochemistry/ Immunofluorescence - Anti-Cofilin (phospho S3) antibody (AB12866)
Immunocytochemistry/ Immunofluorescence analysis of human neuroblastoma cells labeling Cofilin (phospho S3) with ab12866 at 1/500 dilution. Cells were fixed in paraformaldehyde, permeabilized for 15 minutes in 0.01% Triton X-100, blocked using 5% serum for 30 minutes at 20°C, then incubated with ab12866 at a 1/500 dilution for 2 hours at 20°C. The secondary used was a Dylight 488 conjugated donkey anti-rabbit IgG (H+L) used at a 1/500 dilution.
This image is courtesy of an anonymous abreview.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cofilin (phospho S3) antibody (AB12866)
Immunofluorescence analysis of Phospho-Cofilin pSer3 was done on 70% confluent log phase PC-3 cells. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 10 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with ab12866 at 1 : 250 dilution in 0.1% BSA and incubated for 3 hours at room temperature and then labeled with Goat anti-Rabbit IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate at a dilution of 1 : 2000 for 45 minutes at room temperature (Panel a : green). Nuclei (Panel b : blue) were stained with SlowFade® Gold Antifade Mountant with DAPI. F-actin (Panel c : red) was stained with Rhodamine Phalloidin (1 : 300). Panel d is a merged image showing cytoplasmic and nuclear localization. Panel e is a no primary antibody control. The images were captured at 60X magnification.
- WB
Supplier Data
Western blot - Anti-Cofilin (phospho S3) antibody (AB12866)
All lanes:
Western blot - Anti-Cofilin (phospho S3) antibody (ab12866) at 1 µg/mL
Lane 1:
HeLa whole cell extract at 20 µg
Lane 2:
HeLa treated for overnight with 150 uM of H2O2 whole cell extract at 20 µg
Lane 3:
HeLa treated for overnight with 3 uM of Staurosporine whole cell extract at 20 µg
Lane 4:
COS-7 whole cell extract at 20 µg
Lane 5:
NIH/3T3 (Mouse embryo fibroblast cell line) whole cell extract at 20 µg
Lane 6:
MCF7 whole cell extract at 20 µg
Lane 7:
Rat Skeletal Muscle whole cell extract at 20 µg
Lane 8:
A-431 whole cell extract at 20 µg
Lane 9:
A-431 treated for overnight with 150 uM of H2O2 whole cell extract at 20 µg
Lane 10:
Jurkat whole cell extract at 20 µg
Lane 11:
Jurkat treated for overnight with 3 uM of Staurosporine whole cell extract at 20 µg
Secondary
All lanes:
Goat anti-rabbit IgG (H+L), HRP conjugate at 1/2500 dilution
Predicted band size: 18 kDa
Observed band size: 18 kDa
false
- WB
Unknown
Western blot - Anti-Cofilin (phospho S3) antibody (AB12866)
Peptide Competition and Phosphatase Treatment
Lysates prepared from MDCK cells treated with staurosporine (1) or left untreated (2-6) were resolved by SDS-PAGE on a 10% polyacrylamide gel and transferred to PVDF. Membranes were either left untreated (1-5) or treated with lambda phosphatase (6), blocked with a 5% BSA-TBST buffer for one hour at room temperature, and incubated with the ab12866 antibody for two hours at room temperature in a 3% BSA-TBST buffer, following prior incubation with : no peptide (1, 2, 6), the non phosphopeptide corresponding to the immunogen (3), a generic phosphoserine-containing peptide (4) or, the phosphopeptide immunogen (5). After washing, membranes were incubated with goat F(ab)2 anti-rabbit IgG HRP conjugate and bands were detected using the Pierce SuperSignal method. The data show that only the peptide corresponding to cofilin [pS3] blocks the antibody signal. The data also show that phosphatase stripping eliminates the signal, verifying that the anti
All lanes:
Western blot - Anti-Cofilin (phospho S3) antibody (ab12866)
Predicted band size: 18 kDa
false
- WB
CiteAb
Western blot - Anti-Cofilin (phospho S3) antibody (AB12866)
Cofilin (phospho S3) western blot using anti-Cofilin (phospho S3) antibody ab12866. Publication image and figure legend from Pang, D., Yang, C., et al., 2020, Biol Open, PubMed 31988091.
ab12866 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab12866 please see the product overview.
Suppressed cofilin activity was implicated in PP2-inhibited cellular motility of HepG2 and BEL7402 cells. (A–D) Western blots and quantifications show increased phosphorylation of cofilin-1 in the cells treated with 0, 0.5 and 1.0 μM PP2 for 24 h. (E,F) Wound healing assay and quantifications show stably expressed mutant cofilin-1 (S3A) improves cellular motility of HepG2 cells under the treatment of PP2 (1 μM). (G–J) Western blots and quantifications show decreased protein levels of SSH-1 in the cells treated with 0, 0.5 and 1.0 μM PP2 for 24 h. **p<0.01, ***p<0.001. Scale bar : 200 μm.
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Through its interaction with actin filaments cofilin-1 functions to regulate the length and turnover of the actin cytoskeleton within cells. Cofilin-1 is part of a critical complex where it binds to actin monomers and filaments to facilitate the disassembly and recycling of actin. This regulation impacts cellular activities such as migration endocytosis and division influencing how cells respond to internal and external signals. Cofilin-1's ability to bind and sever actin filaments forms an important part of its functional mechanism altering the cytoskeletal architecture for various cellular processes.
Pathways
Cofilin-1 participates principally in the actin dynamics component of the cytoskeleton remodeling pathway. Within this framework cofilin-1 acts alongside other proteins like actin-depolymerizing factor (ADF) and tropomyosin influencing assembly and disassembly cycles of actin filaments. The Rho family of GTPases regulates cofilin-1 activity through signaling pathways such as the Rho/ROCK/LIMK pathway. This signaling regulation affects actin filament organization impacting cellular processes like axonal guidance and directed cell movement.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (82)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:6622 PubMed40681505
2025
Applications
Unspecified application
Species
Unspecified reactive species
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 57:e13152 PubMed38381883
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of nephrology 55:345-360 PubMed38330925
2024
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed38193818
2024
Applications
Unspecified application
Species
Unspecified reactive species
Genes, brain, and behavior 22:e12863 PubMed37575018
2023
Applications
Unspecified application
Species
Unspecified reactive species
Human cell 36:1928-1937 PubMed37548903
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:112845 PubMed37480564
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncogenesis 12:25 PubMed37147294
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oncology 2022:4499876 PubMed35799607
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 9:861371 PubMed35492354
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com